Common bone drug may extend life of replacement joints

December 7, 2011

People who take bisphosphonates after joint replacement surgery are less likely to need a repeat operation, finds a new study published in the British Medical Journal today.

While hip and knee replacements are cost effective procedures, substantial numbers of patients require revision within 10 years to replace the implant because of infection, wear, loosening, or other mechanical failures.

Oral bisphosphonates are used to prevent fractures and to treat common bone diseases like osteoporosis. Some experts think that bisphosphonates may improve the survival time of replacement joints through their effects on reducing , but evidence is scarce and controversial.

So a team of researchers, led by Professor Nigel Arden at the University of Oxford, set out to test whether bisphosphonate use is related to improved implant survival time.

Using data from the General Practice Research Database, which contains anonymised data on three million UK primary care patients, they identified all patients over the age of 40 undergoing hip or from 1986-2006 for osteoarthritis.

Patients who were prescribed bisphosphonates at least six months before revision surgery were defined as bisphosphonate users. Non-users were defined as those who were never prescribed bisphosphonates or who had their first prescription after revision surgery.

Factors that could affect the results, such as age, sex, (BMI), smoking status, , use of calcium and vitamin D supplements, and previous fractures were also taken into account.

Patients were tracked for a maximum of 15 years after their operation to calculate the rate of revision surgery.

Bisphosphonate users had a lower rate of revision rate at five years than non-users. Bisphosphonate use was associated with an almost twofold increase in implant survival time.

The researchers estimate that, for every 107 joint replacement patients taking bisphosphonates, one revision operation would be avoided.

And they suggest that the results could be due to bisphosphonate therapy suppressing the long term inflammatory response around the implant after surgery that often leads to bone loss and loosening of the implant.

Further studies are needed to confirm these findings, write the authors. However, they say that the protective effect of seen in this study can be assumed to be valid for the wider population of patients undergoing total hip or knee replacement in the UK.

Explore further: New hip implants no better than traditional implants

Related Stories

New hip implants no better than traditional implants

November 30, 2011
New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published in the British Medical Journal today.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.